Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cosgrove

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 23, 2018
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosisTsukasa Okamoto, Susan K Mathai, Corinne E Hennessy, et al.
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
Gastrointestinal Cancer Research : GCR|March 19, 2013
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortiumCelina S Ang, R Katie Kelley, Michael A Choti, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Breast Cancer Research : BCR|February 11, 2012
The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activationJoseph P Garay, Bedri Karakas, Abde M Abukhdeir, et al.
Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.
Annals of the American Thoracic Society|December 1, 2018
Optimizing Home Oxygen Therapy. An Official American Thoracic Society Workshop ReportSusan S Jacobs, David J Lederer, Chris M Garvey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2019
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [<sup>11</sup>C]PBR28 HRRT PET studyJouni Tuisku, Pontus Plavén-Sigray, Edward C Gaiser, et al.
Nature Genetics|April 16, 2013
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosisTasha E Fingerlin, Elissa Murphy, Weiming Zhang, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 23, 2018
The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosisTsukasa Okamoto, Susan K Mathai, Corinne E Hennessy, et al.
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
Gastrointestinal Cancer Research : GCR|March 19, 2013
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortiumCelina S Ang, R Katie Kelley, Michael A Choti, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
Breast Cancer Research : BCR|February 11, 2012
The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activationJoseph P Garay, Bedri Karakas, Abde M Abukhdeir, et al.
Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.
Annals of the American Thoracic Society|December 1, 2018
Optimizing Home Oxygen Therapy. An Official American Thoracic Society Workshop ReportSusan S Jacobs, David J Lederer, Chris M Garvey, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2019
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [<sup>11</sup>C]PBR28 HRRT PET studyJouni Tuisku, Pontus Plavén-Sigray, Edward C Gaiser, et al.
Nature Genetics|April 16, 2013
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosisTasha E Fingerlin, Elissa Murphy, Weiming Zhang, et al.
Pageof 32